These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 35501501

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Saccade, Pupil, and Blink Responses in Rapid Eye Movement Sleep Behavior Disorder.
    Perkins JE, Janzen A, Bernhard FP, Wilhelm K, Brien DC, Huang J, Coe BC, Vadasz D, Mayer G, Munoz DP, Oertel WH.
    Mov Disord; 2021 Jul; 36(7):1720-1726. PubMed ID: 33754406
    [Abstract] [Full Text] [Related]

  • 3. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE.
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
    Sako W, Murakami N, Izumi Y, Kaji R.
    Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
    [Abstract] [Full Text] [Related]

  • 6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
    Malkiewicz JJ, Siuda J.
    Neurol Neurochir Pol; 2024 Nov; 58(2):193-202. PubMed ID: 38148738
    [Abstract] [Full Text] [Related]

  • 7. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 8. Comparison of REM sleep behaviour disorder variables between patients with progressive supranuclear palsy and those with Parkinson's disease.
    Nomura T, Inoue Y, Takigawa H, Nakashima K.
    Parkinsonism Relat Disord; 2012 May; 18(4):394-6. PubMed ID: 22115673
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Patterns of Eye Movement Impairment Correlate with Regional Brain Atrophy in Neurodegenerative Parkinsonism.
    Vintonyak O, Gorges M, Müller HP, Pinkhardt EH, Ludolph AC, Huppertz HJ, Kassubek J.
    Neurodegener Dis; 2017 May; 17(4-5):117-126. PubMed ID: 28268209
    [Abstract] [Full Text] [Related]

  • 12. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC.
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [Abstract] [Full Text] [Related]

  • 13. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K.
    Intern Med; 2011 Jul; 50(22):2775-81. PubMed ID: 22082889
    [Abstract] [Full Text] [Related]

  • 14. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.
    Tsukamoto K, Matsusue E, Kanasaki Y, Kakite S, Fujii S, Kaminou T, Ogawa T.
    Neuroradiology; 2012 Sep; 54(9):947-55. PubMed ID: 22274571
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC, Thornton JS, Lees AJ, Jäger HR.
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders.
    Fernandes Gomes B, Farris CM, Ma Y, Concha-Marambio L, Lebovitz R, Nellgård B, Dalla K, Constantinescu J, Constantinescu R, Gobom J, Andreasson U, Zetterberg H, Blennow K.
    Parkinsonism Relat Disord; 2023 Dec; 117():105807. PubMed ID: 37591709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.